<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and skeletal muscle <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction </plain></SENT>
<SENT sid="1" pm="."><plain>We have found that subjects with early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> show incapacity to increase Vo(2max) in response to <z:hpo ids='HP_0011010'>chronic</z:hpo> exercise </plain></SENT>
<SENT sid="2" pm="."><plain>This suggests a defect in muscle <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> response to exercise </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we have explored the nature of the mechanisms involved </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS Muscle biopsies were collected from young type 2 diabetic subjects and <z:mp ids='MP_0001261'>obese</z:mp> control subjects before and after <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> exercise protocols, and the expression of genes and/or proteins relevant to <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function was measured </plain></SENT>
<SENT sid="5" pm="."><plain>In particular, the regulatory pathway peroxisome proliferator-activated receptor gamma coactivator (<z:chebi fb="6" ids="26336">PGC</z:chebi>)-1alpha/mitofusin-2 (Mfn2) was analyzed </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS At baseline, subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> showed reduced expression (by 26%) of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> fusion protein Mfn2 and a 39% reduction of the alpha-subunit of ATP synthase </plain></SENT>
<SENT sid="7" pm="."><plain>Porin expression was unchanged, consistent with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> mass </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> exercise led to a 2.8-fold increase in Mfn2, as well as increases in porin, and the alpha-subunit of ATP synthase in muscle from control subjects </plain></SENT>
<SENT sid="9" pm="."><plain>However, Mfn2 was unchanged after <z:hpo ids='HP_0011010'>chronic</z:hpo> exercise in individuals with <z:mp ids='MP_0002055'>diabetes</z:mp>, whereas porin and alpha-subunit of ATP synthase were increased </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> exercise caused a fourfold increase in <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha expression in muscle from control subjects but not in subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS Our results demonstrate alterations in the regulatory pathway that controls <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha expression and induction of Mfn2 in muscle from patients with early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with early-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> display abnormalities in the exercise-dependent pathway that regulates the expression of <z:chebi fb="6" ids="26336">PGC</z:chebi>-1alpha and Mfn2 </plain></SENT>
</text></document>